Extended Data Fig. 2: Difference in treatment effect based on age, deprivation level (IMD), baseline body mass index (BMI), sex, primary symptom selected (and whether this included fatigue or not). | Nature Medicine

Extended Data Fig. 2: Difference in treatment effect based on age, deprivation level (IMD), baseline body mass index (BMI), sex, primary symptom selected (and whether this included fatigue or not).

From: Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial

Extended Data Fig. 2

Data are presented as means with 95% confidence intervals. Two-sided p-values represent the interaction between subgroup and treatment (linear regression/ANCOVA), exploring age ( < 42.1: n = 71, 42.2 to 51.4: n = 69, >51.4: n = 74, p = 0.5750), IMD (1st to 5th decile: n = 86, 6th to 10th decile: n = 128, p = 0.3191), BMI (Below 30: n = 31, 30 or above: n = 183, p = 0.0861), sex (female: n = 182, male: n = 31, p = 0.2255), primary symptom selected (Pain: n = 26, Breathlessness: n = 35, Fatigue: n = 115, Other: n = 37, p = 0.6053), and fatigue as a primary symptom (Yes: n = 115, No: n = 99, p = 0.3696).

Back to article page